|Bid||79.76 x 1000|
|Ask||79.79 x 800|
|Day's Range||78.38 - 79.79|
|52 Week Range||62.63 - 87.49|
|Beta (5Y Monthly)||0.51|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.11 (0.15%)|
|Ex-Dividend Date||May 04, 2021|
|1y Target Est||85.58|
Segment wise, within Alcon's (ALC) Surgical arm, the portfolio of advanced technology intraocular lenses is driving increased penetration rates of ATIOLs.
Alcon (ALC) records year-over-year growth across all sales categories in Surgical and Vision Care in Q3.
GENEVA, November 10, 2021--Alcon Reports Third Quarter 2021 Results